Necrólisis epidérmica tóxica asociada al uso de ácido valproico

Guevara Campos, José; Benardi Lorenzón, María Luisa; Ibrahim, Gladys; Mejías, Pedro; Agelvis, María Carolina; González de Guevara, Lucía.
Rev. neurol. (Ed. impr.) ; 50(7): 444-445, 1 abr., 2010. ilus
Artículo en Español | IBECS (España) | ID: ibc-82829

Documentos relacionados

  1. Stevens-Johnson syndrome in children.
  2. High risk and low prevalence diseases: Stevens Johnson syndrome and toxic epidermal necrolysis.
  3. Unraveling the genetic link: an umbrella review on HLA-B*15:02 and antiepileptic drug-induced Stevens-Johnson syndrome/toxic epidermal necrolysis.
  4. Toxic epidermal necrolysis and Stevens-Johnson syndrome/toxic epidermal necrolysis overlap in pediatric patients with a focus on newer antiepileptic drugs: A 25-year retrospective study at a single tertiary care center.
  5. Effects of dosage in new users of lamotrigine inducing epidermal necrolysis: Results of the German Registry of Severe Skin Reactions.
  6. Severe cutaneous adverse drug reactions: diagnostic approach and genetic study in a Brazilian case series.
  7. Enfortumab Vedotin-Associated Toxic Epidermal Necrolysis-like Toxic Erythema of Chemotherapy.
  8. Cutaneous Immune-Related Adverse Events Secondary to Immune Checkpoint Inhibitors and Their Management.
  9. APOA4 as a novel predictor of prognosis in Stevens-Johnson syndrome/toxic epidermal necrolysis: A proteomics analysis from two prospective cohorts.
  10. Allopurinol-induced Stevens-Johnson syndrome and toxic epidermal necrolysis: Signal detection and preventability from Vietnam National pharmacovigilance database.